Societal costs of chemotherapy in the UK: an incidence-based cost-of-illness model for early breast cancer.

ABSTRACT:

Aim

To estimate annual societal costs associated with chemotherapy for early breast cancer in the UK.

Design

Mixed methods: (a) an incidence-based cost-of-illness model was developed of indirect costs in patients with breast cancer and carers, and estimated from diagnosis through active treatment until death; (b) interviews with stakeholders were also undertaken to understand actual experiences and impacts of these costs.

Data sources

Model data were collated from relevant national data sources covering general population statistics, UK cancer registries, clinical guidelines and published literature, and patient survey data. Patient and staff views were collected through semistructured interviews.

Participants

Model: patients with early breast cancer receiving

SUBMITTER: Parsekar K 

PROVIDER: S-EPMC8728345 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature